Latest News & Features
Refine Search
Big Pharma
At the PanEuropean IP Summit on Tuesday, a panel discussion revealed different attitudes toward the introduction of the Unitary Patent and Unified Patent Court. 10 December 2013
Americas
Speaking at Wednesday's C5 Congress on Biotech and Pharma Patenting in London, Michael McGraw, a partner from Fitzpatrick, Cella, Harper and Scinto in New York, considered the line that separates natural and man-made products. 5 December 2013
Big Pharma
At the 3rd C5 Forum on Biosimilars in London on Wednesday, a panel of lawyers and regulatory experts discussed the lie of the land for biosimilars. 5 December 2013
Biotechnology
Aliki Nichogiannopoulou, director of biotechnology at the European Patent Office, outlined best practices for patenting antibodies at the office while speaking at the 25th C5 Congress on Biotech and Pharma Patenting in London on Wednesday. 4 December 2013
Big Pharma
Novartis Pharmaceuticals has filed a lawsuit against US drug manufacturer Roxane Laboratories disputing an application for a schizophrenia drug. 3 December 2013
Americas
Orrick Herrington & Sutcliffe LLP has expanded its IP group and hired Grace Pan as partner. 3 December 2013
Asia-Pacific
Takeda has announced that Christophe Weber, a member of GlaxoSmithKline’s global corporate executive team, will be joining the company as chief operating officer by April next year. 2 December 2013
Americas
The US government has said it is now advocating a “differential” approach to policies on patenting drugs as part of continuing trade negotiations with Pacific countries. 29 November 2013
Asia
US investment firm KKR has bought a stake in Indian pharmaceutical company Gland Pharma for approximately $200 million. 29 November 2013
Americas
Genetic diagnostics company Invitae Corporation has requested declaratory judgment at the US District Court for the Northern District of California that it does not infringe 11 patents owned or exclusively licensed to Myriad Genetics. 28 November 2013